The findings from the U.S. Physician & Payer Forum report, “Accountable Care Organizations: How will Payer and Provider Adoption of This Model Impact Prescribing Trends in Asthma and COPD?” are based on survey results from 100 pulmonologists, 39 managed care organization pharmacy directors and two MCO medical directors.
According to the news release, the medical and drug savings from ACOs are expected to come from ACOs’ focus on prescribing lower-cost therapies, patient screenings and drug adherence.
More Articles on Accountable Care Organizations:
Via Christi Health Vying for Medicare ACO
9 Pioneer ACOs Could Back Out of Program
67% of Physicians Report No Personal Financial Benefit From ACOs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
